1996
DOI: 10.1097/00005392-199606000-00011
|View full text |Cite
|
Sign up to set email alerts
|

Prunart Renal Lymphoma

Abstract: Primary renal lymphoma is unusual but not rare. The relatively poor prognosis in our patients could be attributed to the adverse prognostic factors associated with aggressive nodal lymphomas.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2015
2015
2019
2019

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 11 publications
0
4
0
Order By: Relevance
“…2), the diagnosis is not always straightforward. There are many potential mimics, including inflammatory processes with increased lymphocytes, such as inflammatory pseudotumors, abscesses or pyelonephritis [32,33,34,35], or, in post-renal-transplant patients, in acute rejection [36,37,38,39,40]. In addition, although neoplastic cells in renal-cell carcinoma and transitional-cell carcinoma are not typically confused with hematopoietic disease, these tumors may be accompanied by an abundant inflammatory response which may also raise suspicion for lymphoma [41,42].…”
Section: Discussionmentioning
confidence: 99%
“…2), the diagnosis is not always straightforward. There are many potential mimics, including inflammatory processes with increased lymphocytes, such as inflammatory pseudotumors, abscesses or pyelonephritis [32,33,34,35], or, in post-renal-transplant patients, in acute rejection [36,37,38,39,40]. In addition, although neoplastic cells in renal-cell carcinoma and transitional-cell carcinoma are not typically confused with hematopoietic disease, these tumors may be accompanied by an abundant inflammatory response which may also raise suspicion for lymphoma [41,42].…”
Section: Discussionmentioning
confidence: 99%
“…Lenalidomide was dissolved in DMSO as per manufacturer's instructions (Sigma Aldrich, St. Louis, MO). It was diluted in media to 2.3µM immediately prior to use [26]. The treated RPMI-8226 cells were mixed with lenalidomide in the syringe and loaded in the microfluidic device following similar procedure as stated above.…”
Section: Activation Of Nk Cells and Nk-mediated Cytolysis In Dropletsmentioning
confidence: 99%
“…We next assessed the feasibility of screening different types of therapeutic agents, including small molecule drugs and antibody-based inhibitors, using our analytical approach. Here we determined the effect of lenalidomide, a small molecule derivative of thalidomide, in modifying the efficacy of NK cell activity in droplets [26]. This drug is known to activate T and NK cells and improve recognition of malignant cells by NK cells [5,38].…”
Section: Increasing Primary Nk Cell Cytotoxicity With Lenalidomidementioning
confidence: 99%
“…In one study, MRI of spine detected additional foci in four out of 12 patients. [23] In cases of smouldering MM (smouldering myeloma [SM]), MRI detected marrow abnormalities in 30-50% of patients. Furthermore, in one study it was demonstrated that median time to start treatment was 16 months in patients with abnormal MRI compared to 43 months with normal MRI (P < 0.01).…”
Section: Role Of Mri In Solitary Plasmacytoma/smouldering Mm/monoclonmentioning
confidence: 99%